• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Institut Straumann AG BLX ?3.75 RB, SLActive? 10mm, RXD; Endosseous Dental Implant

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Institut Straumann AG BLX ?3.75 RB, SLActive? 10mm, RXD; Endosseous Dental Implant Back to Search Results
Catalog Number 061.4310
Medical Device Problem Code Loss of Osseointegration (2408)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 10/06/2023
Type of Reportable Event Serious Injury
Event or Problem Description
The clinician reports the implant was inserted on (b)(6) 2023 in the patient's mouth.On (b)(6) 2023, loss of osseointegration was verified.Patient presented with bone type iii and poor oral hygiene.No product was returned to the manufacturer.At the event the patient experienced: peri-implantitis.No further patient complications were reported.
 
Additional Manufacturer Narrative
The batch number could be verified.Our manufacturing q-system assures, that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed.? the loss of an endosseous dental implant after successful osseointegration and restoration is a known inherent risk of the procedure.Implants may have to be removed in case one or more of the implant success criteria are not met.Implant success criteria according to buser et al.(1991) are: 1.Absence of persistent subjective complaints such as pain, foreign body sensation and /or dysesthesia.2.Absence of a recurrent peri-implant infection with suppuration.3.Absence of implant mobility.4.Absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported failure rate associated with its dental implants is below the expected failure rate for this treatment as published in the scientific literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLX ?3.75 RB, SLActive? 10mm, RXD
Common Device Name
Endosseous Dental Implant
Manufacturer (Section D)
Institut Straumann AG
peter merian-weg 12
basel 04002
SZ  04002
Manufacturer (Section G)
Institut Straumann AG
peter merian-weg 12
basel 04002
SZ   04002
Manufacturer Contact
jennifer jackson
60 minuteman road
andover, MA 01810
+1(978)747-2509
MDR Report Key50824743
Report Number0009613348-2026-014582
Device Sequence Number13301463
Product Code DZE
UDI-Device Identifier07630031736505
UDI-Public07630031736505
Combination Product (Y/N)N
Initial Reporter CountryLH
PMA/510(K) Number
K181703
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 09/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number061.4310
Device Lot NumberHEY07
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/18/2026
Initial Report FDA Received Date09/18/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/28/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-